The biopharmaceutical industry is in constant flux. Small to medium sized companies create incremental value for shareholders by developing new compounds, devices, and products that they can then commercialize or sell. Josh has been employed by some of the most inquisitive companies in the industry. Thus we are able to offer the following services:

  • Assessment of BOTH likely volume and price via overlaying likely Market Access levels both at launch and throughout the product’s lifecycle
  • Initial design of information to put in your dataroom
  • Assessment (or reassessment) of the product, service, device, or technology’s appeal to payers. Ability to evaluate and credential any completed market access or pricing work
  • Expert advice on how to integrate pricing into partnership and co-promotion licensing agreements

For more information: Transaction and Dataroom support sell sheet 10022017